“Wise Clinical Choices” in an R-RCT, a registry-based randomized clinical trial.
It is designed to be extremely easy to participate in. It is likely that intensive care units that have already implemented changes such as Wise Clinical Choices can also participate, but this depends on how far the process has been taken.
The study has been approved by the Swedish Ethical Review Authority (Ref. No. 2025-01558-01).
Does this sound interesting? Contact the study coordinators below. The study closes for inclusion of departments on October 17. The study is scheduled to start on November 3, when a control month begins, with the first intervention (introduction of Wise Clinical Choices) starting one month later.
Max Bell. Associate Professor, Senior Physician. PMI, Karolinska University Hospital and Karolinska Institute
max.bell@regionstockholm.se
Emma Larsson. Associate Professor, Senior Physician. PMI, Karolinska University Hospital and Karolinska Institute
emma.ca.larsson@regionstockholm.se
Erik Svensk. Senior Physician, MLA IVA Sundsvall
erik.svensk@rvn.se